Enovix (ENVX) Cash & Equivalents (2020 - 2026)

Enovix has reported Cash & Equivalents for 7 years, with the latest figure at $88.8 million in Q2 2026.

• For the quarter ending Q2 2026, Cash & Equivalents fell 53.26% year-over-year to $88.8 million; the trailing twelve-month figure through Apr 2026 stood at $88.8 million (down 53.26% YoY), and the FY2025 full-year result was $106.0 million, down 61.15% from the prior year.
• Cash & Equivalents for Q2 2026 stood at $88.8 million, down from $106.0 million in the prior quarter.
• The five-year high for Cash & Equivalents was $408.2 million in Q2 2022, with the low at $88.8 million in Q2 2026.
• Historically, Cash & Equivalents has averaged $265.4 million across 5 years, with a median of $271.8 million in 2023.
• Annual changes were most pronounced in 2022 — Cash & Equivalents soared 7670.75% — and 2025, when it sank 61.15%.
• Enovix's Cash & Equivalents stood at $349.0 million in 2022, then plunged by 33.2% to $233.1 million in 2023, then climbed by 17.05% to $272.9 million in 2024, then slumped by 61.15% to $106.0 million in 2025, then dropped by 16.28% to $88.8 million in 2026.
• The last three Cash & Equivalents figures came in at $88.8 million (Q2 2026), $106.0 million (Q4 2025), and $335.5 million (Q3 2025), per Business Quant data.